These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 3776829)

  • 21. US FDA calls for technological attack on drug counterfeiting.
    Ault A
    Lancet; 2004 Feb; 363(9410):714. PubMed ID: 15005089
    [No Abstract]   [Full Text] [Related]  

  • 22. MedGuide: at last a long-sought opportunity for patient education about prescription drugs.
    Marwick C
    JAMA; 1997 Mar; 277(12):949-50. PubMed ID: 9091654
    [No Abstract]   [Full Text] [Related]  

  • 23. FDA proposes more stringent pediatric-use labeling of prescription drug products.
    Clin Pharm; 1993 Jan; 12(1):6. PubMed ID: 8428434
    [No Abstract]   [Full Text] [Related]  

  • 24. Which prescription for the illegible and unreadable DTC (direct-to-consumer) brief summary--major surgery or euthanasia?
    Hochhauser M
    Manag Care Q; 2002; 10(3):6-10. PubMed ID: 12476659
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prescription writing.
    Casinelli M
    R I Med J (1976); 1988 Jul; 71(7):261. PubMed ID: 3217693
    [No Abstract]   [Full Text] [Related]  

  • 26. Prescription drug product labeling; medication guide requirements--FDA. Final rule.
    Fed Regist; 1998 Dec; 63(230):66378-400. PubMed ID: 10338877
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Drug safety labeling for doctors.
    Hecht A
    FDA Consum; 1979 Oct; 13(8):12-3. PubMed ID: 10309108
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Content and format of labeling for human prescription drugs; pregnancy labeling; public hearing--FDA. Notice of public hearing; request for comments.
    Fed Regist; 1997 Jul; 62(147):41061-3. PubMed ID: 10169832
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Improving prescription drug labeling.
    Wolf MS; Bailey SC
    N C Med J; 2007; 68(5):340-2. PubMed ID: 18183755
    [No Abstract]   [Full Text] [Related]  

  • 30. Spell out 'acetaminophen' for patients' sake, group says.
    Thompson CA
    Am J Health Syst Pharm; 2011 Oct; 68(19):1768. PubMed ID: 21930631
    [No Abstract]   [Full Text] [Related]  

  • 31. HL7 Structured Product Labeling - electronic prescribing information for provider order entry decision support.
    Schadow G
    AMIA Annu Symp Proc; 2005; 2005():1108. PubMed ID: 16779395
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Encouraging trend on prescription drug information.
    Marwick C
    JAMA; 1997 Jun; 277(22):1746-7. PubMed ID: 9178774
    [No Abstract]   [Full Text] [Related]  

  • 33. From the Food and Drug Administration.
    Nightingale SL
    JAMA; 1996 Oct; 276(14):1128. PubMed ID: 8827954
    [No Abstract]   [Full Text] [Related]  

  • 34. Requirements for FDA-approved patient information spelled out in final rule.
    Am J Health Syst Pharm; 1999 Jan; 56(2):107-8. PubMed ID: 10030523
    [No Abstract]   [Full Text] [Related]  

  • 35. Red sky in the morning: modifying prescription drug labels as a result of postmarket surveillance.
    Jacobson JD; Feigal D
    Food Drug Law J; 2007; 62(3):529-46. PubMed ID: 17915395
    [No Abstract]   [Full Text] [Related]  

  • 36. Pharmacogenomic biomarker information in drug labels approved by the United States food and drug administration: prevalence of related drug use.
    Frueh FW; Amur S; Mummaneni P; Epstein RS; Aubert RE; DeLuca TM; Verbrugge RR; Burckart GJ; Lesko LJ
    Pharmacotherapy; 2008 Aug; 28(8):992-8. PubMed ID: 18657016
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Medication use during pregnancy and lactation: the new FDA drug labeling.
    Tillett J
    J Perinat Neonatal Nurs; 2015; 29(2):97-9. PubMed ID: 25919597
    [No Abstract]   [Full Text] [Related]  

  • 38. Keeping prescription drugs safe and effective.
    Bryan PA
    Am Fam Physician; 1974 Nov; 10(5):189-93. PubMed ID: 4421343
    [No Abstract]   [Full Text] [Related]  

  • 39. FDA labeling status of pediatric medications.
    Yoon EY; Davis MM; El-Essawi H; Cabana MD
    Clin Pediatr (Phila); 2006; 45(1):75-7. PubMed ID: 16429220
    [No Abstract]   [Full Text] [Related]  

  • 40. Drug product expiration dates: practice implications.
    MacDonnell CP; Campbell NA
    Med Health R I; 2002 Apr; 85(4):136-7. PubMed ID: 11989404
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.